FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Likely Regretting Unapproved Antibody Test Policy

[ Price : $8.95]

FDA struggles with policy fallout after allowing dozens of Covid-10 serology (antibody) tests to come onto the market without its ...

Draft Guide on Injector Technical Considerations

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Technical Considerations for Demonstrating Reliability of E...

Braun Recalls Injectable Ceftazidime/Dextrose

[ Price : $8.95]

Braun Medical recalls one lot of ceftazidime for injection (2g) and dextrose for injection (50 ml) in its duplex container due to ...

FDA Efforts to Speed Covid-19 Treatments

[ Price : $8.95]

Top FDA executives outline steps being taken to speed the development of Covid-19 vaccines and therapies.

Multiple Violations in Tenderneeds Fertility Inspection

[ Price : $8.95]

FDA warns Tenderneeds Fertility about multiple regulatory violations in its importation and manufacturing of insemination kits and...

FDA Authorizes First Home Collection Covid Test

[ Price : $8.95]

FDA reauthorizes the emergency use of a LabCorp Covid-19 home collection test kit.

Kimera Labs Marketing Unapproved Biologics: FDA

[ Price : $8.95]

FDA says Kimera Labs should ensure its unapproved exosome products comply with all applicable laws and regulations.

Covid-19 CGMP Adjustments

[ Price : $8.95]

BakerHostetler attorneys say drug companies need to be particularly sensitive to potential Covid-19 issues in CGMP compliance.

Trumps Covid-19 Drug Shows No Benefit: Study

[ Price : $8.95]

A new study shows that the Trump-touted malaria drug hydroxychloroquine does not reduce the risk of mechanical ventilation in pati...

Changes in Evidence Supporting FDA Approvals: Study

[ Price : $8.95]

Medical school and hospital researchers say the quality of clinical evidence used to support drug approvals by FDA has changed in ...